SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs > ImmunoCellular Therapeutics, Ltd. (IMUC)

They may have sold. Hard to say. I'm only angry

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
joseytheoutlawwales Member Profile
 
Followed By 72
Posts 4,833
Boards Moderated 2
Alias Born 12/17/09
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/16/2017 1:44:35 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:52:53 PM
ImmunoCellular Therapeutics Announces First Quarter 2017 Financial Results "PR Newswire (US)" - 5/15/2017 4:06:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/5/2017 4:07:21 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/28/2017 4:31:58 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/28/2017 4:24:19 PM
Proxy Soliciting Materials (revised) (prer14a) "Edgar (US Regulatory)" - 4/24/2017 6:09:13 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/20/2017 4:18:20 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 4/17/2017 4:17:34 PM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 4/4/2017 6:08:08 AM
ImmunoCellular Therapeutics and Memgen Announce Letter of Intent for Potential Joint Immuno-Oncology Collaboration "PR Newswire (US)" - 3/23/2017 6:00:00 AM
ImmunoCellular Therapeutics Receives Audit Opinion With Going Concern Explanation "PR Newswire (US)" - 3/14/2017 4:05:00 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/9/2017 5:14:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/9/2017 4:18:39 PM
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update "PR Newswire (US)" - 3/9/2017 4:05:00 PM
ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on March 9, 2017 "PR Newswire (US)" - 3/6/2017 4:05:00 PM
ImmunoCellular Therapeutics Provides Update on ICT-107 Phase 3 Glioblastoma Trial and Announces Advances in Stem-to-T-Cell Re... "PR Newswire (US)" - 3/6/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/13/2017 4:06:07 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 12/28/2016 7:36:52 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/14/2016 5:04:41 PM
ImmunoCellular Therapeutics Announces Management Changes "PR Newswire (US)" - 12/14/2016 4:05:00 PM
ImmunoCellular Therapeutics Reports Updated Immune Monitoring Data from ICT-107 Phase 2 Trial in Newly Diagnosed Glioblastoma... "PR Newswire (US)" - 11/21/2016 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/18/2016 5:17:26 PM
ImmunoCellular Therapeutics Announces One-for-Forty Reverse Stock Split "PR Newswire (US)" - 11/16/2016 6:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 11/15/2016 6:23:31 AM
joseytheoutlawwales   Friday, 05/11/12 12:42:44 PM
Re: biomanbaba post# 982
Post # of 3637 
They may have sold.
Hard to say.

I'm only angry at myself for not adding more!

Just like the rapid selloff from 1.40 to .95, based on NOTHING, I yelled at friends to buy all they could as I knew we'd be back at $1.40 in a day or two.
I didn't expect the rapid climb to $3+!
A bunch of friends are still quite happy with that call!
Every one of them called me during this dip asking if they should sell.
NO!!!!!!
Was my answer to each.
Don't plan on selling before $15....


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist